Shanghai Sanyou Medical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Shanghai Sanyou Medical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Sanyou Medical Co Ltd (688085) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥34.19 Million ≈ $5.00 Million USD) by net assets (CN¥2.10 Billion ≈ $306.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Sanyou Medical Co Ltd (2016–2024)

Cash flow conversion efficiency of Shanghai Sanyou Medical Co Ltd from 2016 to 2024. This chart illustrates how Shanghai Sanyou Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688085 live share price for real-time trading data and today's change.

Shanghai Sanyou Medical Co Ltd Cash Flow Conversion Ratio Explained

Shanghai Sanyou Medical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Sanyou Medical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Sanyou Medical Co Ltd ranked by their cash flow conversion efficiency. Also see 688085 market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Qingdao Citymedia Co Ltd
SHG:600229
0.000x
RIDLEY CORP. LTD
F:RI6
N/A
Genfit S.A.
PA:GNFT
-0.212x
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
-0.003x
Shenzhen Centralcon Investment Holding Co Ltd
SHE:000042
0.485x
Mensch und Maschine Software SE
F:MUM
0.000x
TTY Biopharm Co Ltd
TWO:4105
0.088x
Yunnan Coal & Energy Co Ltd
SHG:600792
0.097x

Annual Cash Flow Conversion Efficiency for Shanghai Sanyou Medical Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Sanyou Medical Co Ltd from 2016 to 2024. Review Shanghai Sanyou Medical Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.05 Billion
≈ $299.80 Million
CN¥10.96 Million
≈ $1.60 Million
0.005x -95.91%
2023-12-31 CN¥2.04 Billion
≈ $298.91 Million
CN¥267.43 Million
≈ $39.13 Million
0.131x +60.58%
2022-12-31 CN¥1.91 Billion
≈ $279.93 Million
CN¥155.97 Million
≈ $22.82 Million
0.082x -2.32%
2021-12-31 CN¥1.74 Billion
≈ $254.07 Million
CN¥144.92 Million
≈ $21.21 Million
0.083x +65.21%
2020-12-31 CN¥1.53 Billion
≈ $224.53 Million
CN¥77.52 Million
≈ $11.34 Million
0.051x -64.16%
2019-12-31 CN¥437.81 Million
≈ $64.07 Million
CN¥61.72 Million
≈ $9.03 Million
0.141x +142.41%
2018-12-31 CN¥340.24 Million
≈ $49.79 Million
CN¥19.79 Million
≈ $2.90 Million
0.058x -21.95%
2017-12-31 CN¥289.06 Million
≈ $42.30 Million
CN¥21.54 Million
≈ $3.15 Million
0.075x -39.21%
2016-12-31 CN¥158.19 Million
≈ $23.15 Million
CN¥19.39 Million
≈ $2.84 Million
0.123x --

About Shanghai Sanyou Medical Co Ltd

SHG:688085 China Medical Devices
Market Cap
$620.69 Million
CN¥4.24 Billion CNY
Market Cap Rank
#10816 Global
#2930 in China
Share Price
CN¥12.72
Change (1 day)
-0.55%
52-Week Range
CN¥11.41 - CN¥23.21
All Time High
CN¥70.68
About

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more